PL124228B1 - Process for preparing novel 9-hydroxyalkylpurines - Google Patents

Process for preparing novel 9-hydroxyalkylpurines Download PDF

Info

Publication number
PL124228B1
PL124228B1 PL1979218318A PL21831879A PL124228B1 PL 124228 B1 PL124228 B1 PL 124228B1 PL 1979218318 A PL1979218318 A PL 1979218318A PL 21831879 A PL21831879 A PL 21831879A PL 124228 B1 PL124228 B1 PL 124228B1
Authority
PL
Poland
Prior art keywords
npt
evaporated
solution
added
erythro
Prior art date
Application number
PL1979218318A
Other languages
English (en)
Polish (pl)
Other versions
PL218318A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Alfredo Ginersorolia
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of PL218318A1 publication Critical patent/PL218318A1/xx
Publication of PL124228B1 publication Critical patent/PL124228B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Adhesives Or Adhesive Processes (AREA)
PL1979218318A 1978-09-15 1979-09-14 Process for preparing novel 9-hydroxyalkylpurines PL124228B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,804 US4221910A (en) 1978-09-15 1978-09-15 9-(Hydroxy alkyl)purines

Publications (2)

Publication Number Publication Date
PL218318A1 PL218318A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-16
PL124228B1 true PL124228B1 (en) 1983-01-31

Family

ID=25478624

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1979218318A PL124228B1 (en) 1978-09-15 1979-09-14 Process for preparing novel 9-hydroxyalkylpurines
PL1979226651A PL124177B1 (en) 1978-09-15 1979-09-14 Process for preparing novel 9-/hydroxyalkyl/purines

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1979226651A PL124177B1 (en) 1978-09-15 1979-09-14 Process for preparing novel 9-/hydroxyalkyl/purines

Country Status (26)

Country Link
US (1) US4221910A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0009155B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5559188A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE1814T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU527881B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1121818A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS241023B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD146050A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2964059D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK145627C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES484168A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI67847C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR72523B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU180892B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE48826B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL58086A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN153050B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX6270E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO152446C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ191482A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH15921A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL124228B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT70179A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO77559A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU41885B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA793972B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
JPS59135334A (ja) * 1983-01-24 1984-08-03 Kawasaki Steel Corp デジタル式張力測定装置
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
NZ291592A (en) * 1994-07-25 2001-03-30 Michel P Rathbone Use of carbon monoxide dependent guanylyl cyclase modulating purine derivative for treating neurological diseases
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004448A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
SG149829A1 (en) * 2003-10-03 2009-02-27 3M Innovative Properties Co Pyrazolopyridines and analogs thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH443312A (fr) * 1963-10-29 1967-09-15 Ajinomoto Kk Procédé de préparation du 1-N-oxyde d'hypoxanthine et du 1-N-oxyde d'inosine substituée ou non, et utilisation des produits obtenus par ce procédé poutilisation des produits obtenus par ce procédé pour la préparation de la 2,6-dichloro-purine et 9-B-D-ribofuranosyl purine substitua ée ou non
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3813394A (en) * 1969-08-18 1974-05-28 Fujisawa Pharmaceutical Co Purine derivatives having hypocholesterolemic activity
JPS504012A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-12-16 1975-01-16
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant

Also Published As

Publication number Publication date
ES484168A1 (es) 1980-09-01
NZ191482A (en) 1984-04-27
RO77559A (ro) 1982-02-01
FI67847B (fi) 1985-02-28
ATE1814T1 (de) 1982-12-15
YU41885B (en) 1988-02-29
AU5055679A (en) 1980-03-20
IE48826B1 (en) 1985-05-29
IL58086A (en) 1982-04-30
CS241023B2 (en) 1986-03-13
NO792791L (no) 1980-03-18
FI67847C (fi) 1985-06-10
AU527881B2 (en) 1983-03-31
CA1121818A (en) 1982-04-13
PL218318A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-16
DK385579A (da) 1980-03-16
PL124177B1 (en) 1982-12-31
FI792848A7 (fi) 1980-03-16
NO152446B (no) 1985-06-24
PH15921A (en) 1983-04-22
DK145627C (da) 1983-06-20
DK145627B (da) 1983-01-03
EP0009155A1 (en) 1980-04-02
YU224679A (en) 1984-06-30
MX6270E (es) 1985-02-27
EP0009155B1 (en) 1982-11-17
DD146050A5 (de) 1981-01-21
US4221910A (en) 1980-09-09
CS622779A2 (en) 1985-06-13
HU180892B (en) 1983-05-30
DE2964059D1 (en) 1982-12-23
NO152446C (no) 1985-10-02
IN153050B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-05-26
IL58086A0 (en) 1979-12-30
ZA793972B (en) 1980-09-24
GR72523B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-11-16
IE791752L (en) 1980-03-15
JPS5559188A (en) 1980-05-02
PT70179A (en) 1979-10-01
JPH031310B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-01-10

Similar Documents

Publication Publication Date Title
PL124228B1 (en) Process for preparing novel 9-hydroxyalkylpurines
AU597483B2 (en) Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof for nucleic acid sequencing and as antiviral agents
US6211158B1 (en) Desazapurine-nucleotide derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof for nucleic acid sequencing and as antiviral agents
CS203092B2 (en) Method of preparing substituted purines
NO161116B (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme purinderivater.
Montgomery et al. 9-(2-Deoxy-2-fluoro-. beta.-D-arabinofuranosyl) guanine: a metabolically stable cytotoxic analogue of 2'-deoxyguanosine
WO1992020347A1 (en) 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
PL124515B1 (en) Process for preparing novel complex compounds of 6-substituted 9-/hydroxyalkyl/purines
EP0242482A2 (en) Antiviral purine derivatives and process for their preparation
Montgomery et al. Synthesis and biological evaluation of 2-fluoro-8-azaadenosine and related compounds
Seita et al. The synthesis of nucleoside and nucleotide analogs
US3992531A (en) 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
Secrist III et al. Syntheses of phosphonate analogues of dideoxyadenosine (DDA)-, dideoxycytidine (DDC)-, dideoxyinosine (DDI)-, and deoxythymidine (DDT)-5′-monophosphates
Sufrin et al. Targeting 5'-deoxy-5'-(methylthio) adenosine phosphorylase by 5'-haloalkyl analogs of 5'-deoxy-5'-(methylthio) adenosine
WO1989005817A1 (en) Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds
Mornet et al. Active cytokinins: photoaffinity labeling agents to detect binding
Konkel et al. Synthesis and Biological Activity of Cyclohexenyl Nucleosides. cis-5-(9 H-Purin-9-yl)-3-cyclohexenyl Carbinols and Their 8-Azapurinyl Analogs
Shealy et al. Carbocyclic analogs of 6-substituted purine ribonucleosides and of adenosine ribonucleotides
PT87705B (pt) Processo para a preparacao de derivados de 6-desoxi-guanina
Otter et al. A corrected structure for pyrrolosine
Zhou et al. 6-isobutyrylaminopurine: A convenient building block for the synthesis of carbocyclic adenosine analogs
KANEKO et al. Synthesis of N6-or 8-Substituted 9-(β-D-Arabinofuranosyl)-adenines and Their Antiviral Activities against Herpes Simplex and Vaccinia Viruses
Hubert–Habart et al. Reaction of azide ion with 9-[2, 3-anhydro-5-O-(p-tolylsulfonyl)-β-D-lyxofuranosyl] adenine
KR830000709B1 (ko) 9-(하이드록시알킬) 푸린류의 제조방법
DK147824B (da) Analogifremgangsmaade til fremstilling af 9-(2-acyloxyethoxymethyl)-puriner eller salte deraf